None listed
Conditions
Brief summary
To demonstrate the prevalence of polycystic ovary syndrome in fertile and infertile women.
Interventions
Prevalence Of Polycystic Ovary Syndrome. Prevalence of PCOS is the proportion of a population found to have a PCOS among study group. Fertile and infertile patients attending infertility clinic fulfilling inclusion and exclusion criteria over 16 months duration were recruited.PCOS was diagnosed by the presence of two or more of the following; clinical and/or biochemical hyperandrogenism, menstrual disorders and polycystic ovaries in transvaginal ultrasound. The clinical assessment of hirsutism is subjective, and it is important to consider the patient’s perception of unwanted hair growth in addition to the perceived rate and timing of hair growth onset. Hirsutism was referred to the growth of coarse, dark hair in areas without hair at all or where fine hair typically grows or, and takes male pattern distribution; above the lip and on the chin, chest, abdomen, and back. Free testosterone (free T) was used to assess hyperandrogenism. Polycystic ovaries were identified by vaginal ultrasound, conducted in the follicular phase or when hormonal assessment showed no follicular activity. A positive finding of polycystic ovaries required either 12 or more follicles measuring 2–9 mm in diameter, or increased ovarian volume (10 cm) in at least one of the ovaries. Each woman was assessed once.
Sponsors
Eligibility
Inclusion criteria
middle aged female, on IUCD for contraception and her last delivery was for at least 2 years. An inclusion criterion for infertile women was primary or secondary infertility for variable periods i.e. more than one year for primary infertility and two years for secondary infertility without upper limit.
Exclusion criteria
pregnant or breast-feeders, if they did not accept to complete the study steps, if they reported being menopausal, using hormone replacement therapy or hormonal contraception, if they had a hysterectomy or oophorectomy, presence of any other etiologies of androgen excess, known hypothyroid patients and patients missing information about cycle regularity